(ENB) Enbridge - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA29250N1050
Stock: Oil Pipelines, Gas Pipelines, Gas Utilities, Renewable Energy
Total Rating 62
Risk 53
Buy Signal 0.23
| Risk 5d forecast | |
|---|---|
| Volatility | 15.8% |
| Relative Tail Risk | 3.08% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.58 |
| Alpha | 27.32 |
| Character TTM | |
|---|---|
| Beta | 0.088 |
| Beta Downside | -0.003 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.86% |
| CAGR/Max DD | 1.14 |
EPS (Earnings per Share)
Revenue
Description: ENB Enbridge March 05, 2026
Enbridge Inc. is an energy infrastructure company operating across four segments. These segments include Liquids Pipelines, Gas Transmission, Gas Distribution and Storage, and Renewable Power Generation.
The Liquids Pipelines segment transports and stores crude oil and other liquid hydrocarbons, primarily in Canada and the United States. This segment also engages in commodity marketing. The Gas Transmission segment focuses on natural gas pipelines and processing facilities in North America. These assets are crucial for moving energy from production basins to consumption centers.
The Gas Distribution and Storage segment provides natural gas utility services to residential, commercial, and industrial customers, predominantly in Ontario and Quebec. This business model often involves regulated tariffs and long-term contracts. The Renewable Power Generation segment operates various renewable energy assets, including wind and solar facilities, across North America.
Enbridge Inc. was founded in 1949 and is headquartered in Calgary, Canada. Further analysis of Enbridges financial performance and operational metrics can be found on ValueRay.
Headlines to watch out for
- Crude oil pipeline volumes impact Liquids Pipelines revenue
- Natural gas transmission demand affects Gas Transmission earnings
- Regulatory approvals for new pipeline projects are crucial
- Interest rate changes influence financing costs
- Renewable energy project development drives growth
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 7.49b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -1.40 > 1.0 |
| NWC/Revenue: -27.92% < 20% (prev -19.91%; Δ -8.01% < -1%) |
| CFO/TA 0.06 > 3% & CFO 12.27b > Net Income 7.49b |
| Net Debt (104.16b) to EBITDA (20.45b): 5.09 < 3 |
| Current Ratio: 0.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.19b) vs 12m ago -1.86% < -2% |
| Gross Margin: 32.97% > 18% (prev 0.36%; Δ 3.26k% > 0.5%) |
| Asset Turnover: 29.81% > 50% (prev 24.42%; Δ 5.39% > 0%) |
| Interest Coverage Ratio: 2.96 > 6 (EBITDA TTM 20.45b / Interest Expense TTM 4.99b) |
Altman Z'' -0.03
| A: -0.08 (Total Current Assets 2.80b - Total Current Liabilities 21.00b) / Total Assets 218.47b |
| B: -0.10 (Retained Earnings -21.28b / Total Assets 218.47b) |
| C: 0.07 (EBIT TTM 14.79b / Avg Total Assets 218.72b) |
| D: 0.36 (Book Value of Equity 55.27b / Total Liabilities 152.55b) |
| Altman-Z'' Score: -0.03 = B |
Beneish M -2.90
| DSRI: 0.80 (Receivables 7.17b/7.38b, Revenue 65.19b/53.47b) |
| GMI: 1.09 (GM 32.97% / 36.03%) |
| AQI: 1.13 (AQ_t 0.38 / AQ_t-1 0.34) |
| SGI: 1.22 (Revenue 65.19b / 53.47b) |
| TATA: -0.02 (NI 7.49b - CFO 12.27b) / TA 218.47b) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of ENB shares?
As of March 15, 2026, the stock is trading at USD 53.64 with a total of 3,251,228 shares traded.
Over the past week, the price has changed by +0.04%, over one month by +1.69%, over three months by +14.91% and over the past year by +34.50%.
Over the past week, the price has changed by +0.04%, over one month by +1.69%, over three months by +14.91% and over the past year by +34.50%.
Is ENB a buy, sell or hold?
Enbridge has received a consensus analysts rating of 3.65.
Therefor, it is recommend to hold ENB.
- StrongBuy: 8
- Buy: 2
- Hold: 11
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the ENB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 51.3 | -4.4% |
| Analysts Target Price | 51.3 | -4.4% |
ENB Fundamental Data Overview March 15, 2026
P/E Trailing = 22.9532
P/E Forward = 23.753
P/S = 1.8052
P/B = 2.9047
P/EG = 1.8185
Revenue TTM = 65.19b USD
EBIT TTM = 14.79b USD
EBITDA TTM = 20.45b USD
Long Term Debt = 98.96b USD (from longTermDebt, last quarter)
Short Term Debt = 6.29b USD (from shortTermDebt, last quarter)
Debt = 105.25b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 104.16b USD (from netDebt column, last quarter)
Enterprise Value = 221.85b USD (117.69b + Debt 105.25b - CCE 1.09b)
Interest Coverage Ratio = 2.96 (Ebit TTM 14.79b / Interest Expense TTM 4.99b)
EV/FCF = 71.45x (Enterprise Value 221.85b / FCF TTM 3.10b)
FCF Yield = 1.40% (FCF TTM 3.10b / Enterprise Value 221.85b)
FCF Margin = 4.76% (FCF TTM 3.10b / Revenue TTM 65.19b)
Net Margin = 11.49% (Net Income TTM 7.49b / Revenue TTM 65.19b)
Gross Margin = 32.97% ((Revenue TTM 65.19b - Cost of Revenue TTM 43.70b) / Revenue TTM)
Gross Margin QoQ = 33.02% (prev 32.47%)
Tobins Q-Ratio = 1.02 (Enterprise Value 221.85b / Total Assets 218.47b)
Interest Expense / Debt = 1.15% (Interest Expense 1.22b / Debt 105.25b)
Taxrate = 13.23% (325.0m / 2.46b)
NOPAT = 12.83b (EBIT 14.79b * (1 - 13.23%))
Current Ratio = 0.13 (Total Current Assets 2.80b / Total Current Liabilities 21.00b)
Debt / Equity = 1.69 (Debt 105.25b / totalStockholderEquity, last quarter 62.33b)
Debt / EBITDA = 5.09 (Net Debt 104.16b / EBITDA 20.45b)
Debt / FCF = 33.55 (Net Debt 104.16b / FCF TTM 3.10b)
Total Stockholder Equity = 60.71b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.42% (Net Income 7.49b / Total Assets 218.47b)
RoE = 12.34% (Net Income TTM 7.49b / Total Stockholder Equity 60.71b)
RoCE = 9.26% (EBIT 14.79b / Capital Employed (Equity 60.71b + L.T.Debt 98.96b))
RoIC = 7.93% (NOPAT 12.83b / Invested Capital 161.77b)
WACC = 3.77% (E(117.69b)/V(222.94b) * Re(6.24%) + D(105.25b)/V(222.94b) * Rd(1.15%) * (1-Tc(0.13)))
Discount Rate = 6.24% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 1.59%
[DCF] Terminal Value 85.57% ; FCFF base≈4.34b ; Y1≈4.03b ; Y5≈3.68b
[DCF] Fair Price = 3.06 (EV 110.83b - Net Debt 104.16b = Equity 6.67b / Shares 2.18b; r=5.90% [WACC]; 5y FCF grow -8.97% → 2.90% )
EPS Correlation: -5.18 | EPS CAGR: 1.25% | SUE: 1.25 | # QB: 1
Revenue Correlation: 48.77 | Revenue CAGR: 3.50% | SUE: 1.38 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.64 | Chg7d=-0.022 | Chg30d=-0.024 | Revisions Net=-2 | Analysts=8
EPS current Year (2026-12-31): EPS=2.98 | Chg7d=-0.011 | Chg30d=-0.077 | Revisions Net=-2 | Growth EPS=-1.3% | Growth Revenue=-5.8%
EPS next Year (2027-12-31): EPS=3.21 | Chg7d=-0.006 | Chg30d=-0.070 | Revisions Net=-3 | Growth EPS=+7.6% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.6% (Discount Rate 7.9% - Earnings Yield 4.4%)
[Growth] Growth Spread = -3.6% (Analyst -0.1% - Implied 3.6%)
P/E Forward = 23.753
P/S = 1.8052
P/B = 2.9047
P/EG = 1.8185
Revenue TTM = 65.19b USD
EBIT TTM = 14.79b USD
EBITDA TTM = 20.45b USD
Long Term Debt = 98.96b USD (from longTermDebt, last quarter)
Short Term Debt = 6.29b USD (from shortTermDebt, last quarter)
Debt = 105.25b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 104.16b USD (from netDebt column, last quarter)
Enterprise Value = 221.85b USD (117.69b + Debt 105.25b - CCE 1.09b)
Interest Coverage Ratio = 2.96 (Ebit TTM 14.79b / Interest Expense TTM 4.99b)
EV/FCF = 71.45x (Enterprise Value 221.85b / FCF TTM 3.10b)
FCF Yield = 1.40% (FCF TTM 3.10b / Enterprise Value 221.85b)
FCF Margin = 4.76% (FCF TTM 3.10b / Revenue TTM 65.19b)
Net Margin = 11.49% (Net Income TTM 7.49b / Revenue TTM 65.19b)
Gross Margin = 32.97% ((Revenue TTM 65.19b - Cost of Revenue TTM 43.70b) / Revenue TTM)
Gross Margin QoQ = 33.02% (prev 32.47%)
Tobins Q-Ratio = 1.02 (Enterprise Value 221.85b / Total Assets 218.47b)
Interest Expense / Debt = 1.15% (Interest Expense 1.22b / Debt 105.25b)
Taxrate = 13.23% (325.0m / 2.46b)
NOPAT = 12.83b (EBIT 14.79b * (1 - 13.23%))
Current Ratio = 0.13 (Total Current Assets 2.80b / Total Current Liabilities 21.00b)
Debt / Equity = 1.69 (Debt 105.25b / totalStockholderEquity, last quarter 62.33b)
Debt / EBITDA = 5.09 (Net Debt 104.16b / EBITDA 20.45b)
Debt / FCF = 33.55 (Net Debt 104.16b / FCF TTM 3.10b)
Total Stockholder Equity = 60.71b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.42% (Net Income 7.49b / Total Assets 218.47b)
RoE = 12.34% (Net Income TTM 7.49b / Total Stockholder Equity 60.71b)
RoCE = 9.26% (EBIT 14.79b / Capital Employed (Equity 60.71b + L.T.Debt 98.96b))
RoIC = 7.93% (NOPAT 12.83b / Invested Capital 161.77b)
WACC = 3.77% (E(117.69b)/V(222.94b) * Re(6.24%) + D(105.25b)/V(222.94b) * Rd(1.15%) * (1-Tc(0.13)))
Discount Rate = 6.24% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 1.59%
[DCF] Terminal Value 85.57% ; FCFF base≈4.34b ; Y1≈4.03b ; Y5≈3.68b
[DCF] Fair Price = 3.06 (EV 110.83b - Net Debt 104.16b = Equity 6.67b / Shares 2.18b; r=5.90% [WACC]; 5y FCF grow -8.97% → 2.90% )
EPS Correlation: -5.18 | EPS CAGR: 1.25% | SUE: 1.25 | # QB: 1
Revenue Correlation: 48.77 | Revenue CAGR: 3.50% | SUE: 1.38 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.64 | Chg7d=-0.022 | Chg30d=-0.024 | Revisions Net=-2 | Analysts=8
EPS current Year (2026-12-31): EPS=2.98 | Chg7d=-0.011 | Chg30d=-0.077 | Revisions Net=-2 | Growth EPS=-1.3% | Growth Revenue=-5.8%
EPS next Year (2027-12-31): EPS=3.21 | Chg7d=-0.006 | Chg30d=-0.070 | Revisions Net=-3 | Growth EPS=+7.6% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.6% (Discount Rate 7.9% - Earnings Yield 4.4%)
[Growth] Growth Spread = -3.6% (Analyst -0.1% - Implied 3.6%)